Family
Guarigione
Peptides with described effects on tissue healing, wound closure or mucosal protection — predominantly preclinical evidence.
This family covers synthetic peptides whose published observations relate to repair processes: tendon and ligament healing, wound closure, gastric mucosal protection, angiogenesis. The evidence base comes almost entirely from animal models and cell culture. Controlled human trials are rare and limited in quality and scope.
This overview is editorial. It describes the evidence base, not a usage recommendation.
Members
6 entries in this familyBPC-157
Modello animale5 studies · 4 observations
Synthetic peptide derived from a sequence of a protein found in gastric juice. In preclinical models, an influence on angiogenic and tissue-protective signallin…
KPV
Modello animale4 studies · 5 observations
KPV is the C-terminal fragment of α-melanocyte-stimulating hormone (α-MSH). In preclinical models the inflammation-modulating activity is attributed predominant…
TB-500
Modello animale3 studies · 4 observations
Synthetic fragment of the endogenous protein Thymosin Beta-4. In preclinical models, an influence on cell migration, actin sequestration and neovascularisation …
Thymalin
Studio sull'uomo4 studies · 3 observations
Thymalin is a complex of multiple polypeptides extracted from bovine or calf thymus. Postulated mechanisms include modulation of T-lymphocyte maturation, influe…
Thymosin Alpha-1
RCT sull'uomo4 studies · 3 observations
Thymosin Alpha-1 is an N-terminally acetylated peptide originally isolated from the thymus. It modulates T-lymphocyte maturation and function and acts on dendri…
Thymosin Beta-4
Studio sull'uomo4 studies · 4 observations
Thymosin Beta-4 forms a 1:1 complex with monomeric (G-)actin and is regarded as the principal actin-sequestering factor in many cell types, thereby influencing …